Key Takeaways
- Morgan Stanley shifted CAVA from equal weight to overweight, increasing the price target from $86 to $90
- Shares jumped 3% Wednesday following Tuesday’s close at $69.97
- Brian Harbour, the covering analyst, highlighted positive momentum in traffic, expansion, and profitability metrics
- Most recent quarterly results exceeded expectations with $0.20 EPS versus $0.17 projected and 32.1% revenue growth year-over-year
- Wall Street consensus among 28 covering analysts indicates “Moderate Buy” with average target of $93.38
Shares of CAVA Group advanced 3% during Wednesday’s morning session following Morgan Stanley’s decision to upgrade the Mediterranean restaurant chain to overweight while establishing a new $90 price objective, up from the previous $86 mark.
The equity had settled at $69.97 on Tuesday, coming off a recent decline attributed to weaker credit card spending data. This temporary weakness seemingly created the opportunity that caught Morgan Stanley’s eye.
Brian Harbour, the analyst behind the call, indicated that the stock’s recent decline motivated the rating change. “We don’t have concerns about longer-term fundamentals and have long had a positive bias towards the story,” he noted in his research commentary.
Harbour identified CAVA as standing out among restaurant sector growth plays, pointing to multiple positive indicators aligning simultaneously â customer traffic expansion, new location openings, strong performance at recently opened units, and clear profit margin trajectory all pointing upward.
Regarding valuation considerations, Harbour conceded the shares aren’t trading at a discount, even after the recent price weakness. However, he maintained the elevated multiple is justified: “Valuation is defensible, because it remains one of the strongest fundamental stories in restaurants.”
The upgraded $90 target price was derived using enterprise value-to-EBITDA multiples and validated through discounted cash flow modeling.
Wall Street Coverage Overview
Among the 28 firms providing research on CAVA, the consensus recommendation is “Moderate Buy.” This includes 17 buy ratings, nine holds, one sell recommendation, and one strong buy. The mean price objective across all analysts stands at $93.38 for the next twelve months.
Royal Bank of Canada maintains among the highest targets at $105 with an outperform rating. JPMorgan and TD Cowen have established $90 and $100 targets respectively, both carrying buy-equivalent recommendations. DA Davidson has set an $84 objective with a neutral stance.
Latest Financial Results and Ownership Trends
CAVA delivered impressive results in its latest quarterly report. The company posted earnings per share of $0.20, surpassing the Street’s $0.17 estimate, while revenue reached $438.27 million â significantly exceeding the $360.89 million projection and representing 32.1% growth compared to the prior-year period.
Over the past year, shares have traded in a range from $43.41 to $98.79. Current technical indicators show the 50-day moving average at $79.32 and the 200-day at $76.94, placing the stock below both short-term and longer-term averages.
Institutional holders control 73.15% of outstanding shares. Multiple major investment firms have expanded their positions recently, including Capital Research Global Investors, which increased its stake by 27.2%, and Alliancebernstein, which approximately doubled its holdings.
Regarding insider transactions, CFO Tricia Tolivar divested roughly 4,969 shares in June at $89.43 per share, while insider Kelly Costanza sold 12,490 shares at $90.00. Both transactions were structured to cover tax obligations on vesting equity compensation rather than reflecting a change in company outlook.
Wall Street analysts currently forecast CAVA will achieve full-year earnings per share of $0.55 for the current fiscal year.





